NZX

1-[6-[3-cyclohexyl-5-methyl-4-(5-methyl-1~{H}-indazol-4-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]propan-1-one

Created:	2022-08-25
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where NZX is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	68
Chiral Atom Count	0
Bond Count	73
Aromatic Bond Count	15

2D diagram of NZX

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-[6-[3-cyclohexyl-5-methyl-4-(5-methyl-1~{H}-indazol-4-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]propan-1-one
Synonyms	1-[6-[3-cyclohexyl-5-methyl-4-(5-methyl-1H-indazol-4-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one (precursor)
Systematic Name (OpenEye OEToolkits)	1-[6-[3-cyclohexyl-5-methyl-4-(5-methyl-1~{H}-indazol-4-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]propan-1-one
Formula	C₂₇ H₃₅ N₅ O
Molecular Weight	445.6
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CCC(=O)N1CC2(CC(C2)n3nc(C4CCCCC4)c(c3C)c5c(C)ccc6[nH]ncc56)C1
SMILES	OpenEye OEToolkits	3.1.0.0	CCC(=O)N1CC2(C1)CC(C2)n3c(c(c(n3)C4CCCCC4)c5c(ccc6c5cn[nH]6)C)C
Canonical SMILES	CACTVS	3.385	CCC(=O)N1CC2(CC(C2)n3nc(C4CCCCC4)c(c3C)c5c(C)ccc6[nH]ncc56)C1
Canonical SMILES	OpenEye OEToolkits	3.1.0.0	CCC(=O)N1CC2(C1)CC(C2)n3c(c(c(n3)C4CCCCC4)c5c(ccc6c5cn[nH]6)C)C
InChI	InChI	1.06	InChI=1S/C27H35N5O/c1-4-23(33)31-15-27(16-31)12-20(13-27)32-18(3)25(26(30-32)19-8-6-5-7-9-19)24-17(2)10-11-22-21(24)14-28-29-22/h10-11,14,19-20H,4-9,12-13,15-16H2,1-3H3,(H,28,29)
InChIKey	InChI	1.06	HIPMOJFZOLBRKR-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	166001312

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.